yeah I would think there is significant weight placed on Phase 1 and phase 2 results as opposed to pre- clinical.
It is good what IMU are showing - but it’s still preclinical.
When IMU had Hervaxx preso last year it was PS this was phase 2.
Perhaps Asx has another beyond preclinical as PS
Ann: onCARlytics to be showcased in three abstracts at SITC, page-12
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $371.8M | |||
| Open | High | Low | Value | Volume |
| 5.0¢ | 5.0¢ | 4.8¢ | $521.9K | 10.58M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 17 | 1612511 | 4.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.0¢ | 3882781 | 14 |
View Market Depth
| Last trade - 16.10pm 02/10/2024 (20 minute delay) ? |
| IMU (ASX) Chart |